Sana Biotechnology benefits from Trump-era tariffs and onshoring trends, with Morgan Stanley analyst coverage starting on August 1, 2025.
2 reports, 1 independent
Updated Aug 1
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Sana Biotechnology benefits from Trump-era tariffs and onshoring trends, with Morgan Stanley analyst coverage starting on August 1, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Sana Biotechnology benefits from Trump-era tariffs and onshoring, gaining coverage from Morgan Stanley.1 source
Sana Biotechnology is leveraging its technology with engineered cells in the US and has formed agreements with Harvard College.1 source
Keep exploring
The entities involved
-
Sana Biotechnology
biotechnology company
Nothing else this week.
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Morgan Stanley
U.S. investment bank
Related events
- Micron benefits from Trump-era tariffs and onshoring trend.
- Barclays raised its price target for Okta, noting that AI stocks are benefiting from the onshoring trend and Trump-era tariffs.
- Trump-era tariffs are reportedly benefiting certain AI stocks, coinciding with the spin-off of Millrose Properties, Inc. from Lennar Corporation.
- Trump's tariff plan caused market tanking, an event that occurred on August 22, 2025.
- Trump's policies, including tariffs and onshoring, are being discussed in the context of their potential benefits for AI stocks, with specific attention paid to Moderna's performance and guidance.
Coverage
Newest first; wire copies grouped- Insider MonkeyCiti Remains Bullish on Sana Biotechnology (SANA) Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the best biotech penny stocks to buy right now. Citi analyst Samantha Semenkow maintained a bullish
- Insider MonkeySana Biotechnology, Inc. (SANA) Secures an Overweight Rating from Morgan Stanley Sana Biotechnology, Inc. (NASDAQ:SANA) is among the fundamentally strong penny stocks to invest in. Morgan Stanley has